Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
MannKind Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
MannKind Corp, Medical Devices Deals, 2012 to YTD 2018 10
MannKind Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
MannKind Corp, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
MannKind Enters into Distribution Agreement with Tanner Pharma 12
MannKind to Enter into Marketing and Distribution Agreement with Cipla 13
MannKind and Biomm Enter into Distribution Agreement 14
MannKind Partners with JDRF 15
Licensing Agreements 16
United Therapeutics Enters into Licensing Agreement with MannKind 16
Receptor Life Sciences Enters into Licensing Agreement with MannKind 17
Colby Enters Into Licensing Agreement With MannKind For Cancer Immunotherapy Products 18
MannKind Enters Into Licensing Agreement With Tolero Pharma For Bruton’s Tyrosine Kinase Inhibitors 20
Equity Offering 21
MannKind Raises USD28 Million in Private Placement of Shares 21
Mannkind to Raise USD61 Million in Private Placement of Shares 23
MannKind Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 25
MannKind Raises USD36.2 Million in Private Placement of Shares 26
Mannkind Raises USD50 Million in Private Placment of Shares 27
MannKind Announces Public Offering Of Common Stock For US$50 Million 29
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 30
MannKind Completes Public Offering Of Units For US$86 Million 32
Debt Offering 34
MannKind Completes First Tranche Of Private Placement Of Notes For US$40 Million 34
MannKind Corp – Key Competitors 36
MannKind Corp – Key Employees 37
MannKind Corp – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Strategy And Business Planning 39
Sep 05, 2018: MannKind and United Therapeutics to advance dry powder treprostinil 39
Financial Announcements 40
Nov 01, 2018: MannKind reports 2018 third quarter financial results 40
Aug 02, 2018: MannKind Reports 2018 Second Quarter Financial Results Conference Call to Begin Today at 5:00 PM ET 42
May 09, 2018: MannKind Reports 2018 First Quarter Financial Results 44
Feb 27, 2018: MannKind Reports 2017 Fourth Quarter and Full Year Financial Results 45
Nov 07, 2017: MannKind Reports 2017 Third Quarter Financial Results 47
Aug 07, 2017: MannKind Reports 2017 Second Quarter Financial Results 49
May 10, 2017: MannKind Reports 2017 First Quarter Financial Results 51
Mar 16, 2017: MannKind Reports 2016 Fourth Quarter and Full Year Financial Results 52
Corporate Communications 53
Jun 25, 2018: MannKind Set to Join Russell 3000 Index 53
Feb 06, 2018: MannKind Names David Kendall As Chief Medical Officer 54
Jul 17, 2017: Steven Binder Joins MannKind as Chief Financial Officer 55
Jul 12, 2017: Patrick McCauley Joins MannKind as Chief Commercial Officer 56
Jan 04, 2017: MannKind Announces Key Addition to Its Executive Management Ranks 57
Product News 58
08/17/2018: NUI Galway finds new treatment strategy for breast cancer relapse 58
Mar 08, 2017: MannKind and Charles Mattocks Announce “REVERSED”-America’s First Docu-Series Tackling Diabetes 59
02/01/2017: MannKind Announces Launch of New Titration Pack and Field Force Expansion to Accelerate Afrezza Growth 60
Other Significant Developments 61
Jan 09, 2017: MannKind Receives $30.6 Million From Sanofi 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62
MannKind Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
MannKind Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
MannKind Corp, Deals By Therapy Area, 2012 to YTD 2018 9
MannKind Corp, Medical Devices Deals, 2012 to YTD 2018 10
MannKind Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
MannKind Enters into Distribution Agreement with Tanner Pharma 12
MannKind to Enter into Marketing and Distribution Agreement with Cipla 13
MannKind and Biomm Enter into Distribution Agreement 14
MannKind Partners with JDRF 15
United Therapeutics Enters into Licensing Agreement with MannKind 16
Receptor Life Sciences Enters into Licensing Agreement with MannKind 17
Colby Enters Into Licensing Agreement With MannKind For Cancer Immunotherapy Products 18
MannKind Enters Into Licensing Agreement With Tolero Pharma For Bruton’s Tyrosine Kinase Inhibitors 20
MannKind Raises USD28 Million in Private Placement of Shares 21
Mannkind to Raise USD61 Million in Private Placement of Shares 23
MannKind Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 25
MannKind Raises USD36.2 Million in Private Placement of Shares 26
Mannkind Raises USD50 Million in Private Placment of Shares 27
MannKind Announces Public Offering Of Common Stock For US$50 Million 29
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 30
MannKind Completes Public Offering Of Units For US$86 Million 32
MannKind Completes First Tranche Of Private Placement Of Notes For US$40 Million 34
MannKind Corp, Key Competitors 36
MannKind Corp, Key Employees 37
MannKind Corp, Other Locations 38
MannKind Corp, Subsidiaries 38
List of Figures
MannKind Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
MannKind Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
MannKind Corp, Medical Devices Deals, 2012 to YTD 2018 10